Patents by Inventor Yukiko Moriya

Yukiko Moriya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220265698
    Abstract: Provided is a composition capable of enhancing the effect of an antibody drug such as an immune checkpoint inhibitor, etc. A ?-glucan is used as an active ingredient of a composition for enhancing the effect of an antibody drug. This composition is used suitably for antibody drugs that have an effect of suppressing growth of cancer via immune checkpoint inhibition; e.g., antibody drugs including a monoclonal antibody to PD-L1.
    Type: Application
    Filed: September 10, 2020
    Publication date: August 25, 2022
    Applicants: AUREO CO., LTD., NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT
    Inventors: Ko RII, Masayuki FUJINO, Yukiko MORIYA
  • Publication number: 20150297651
    Abstract: The present invention provides a living body healing, having an accelerating activity in the regeneration ability relating to the cure of damages of cells or tissues caused by toxicity of a drug or a wound in a living body, having high safety, and also not causing any side effect even administered for a long period of time. Problems are solved by a living body healing accelerator containing as an active constituent a mixture of a culture solution obtained after cultivation of a microorganism belonging to the Aureobasidium sp. and mycelia of the microorganism cultivated in the culture solution. The living body healing accelerator of the present invention is preferable used for reducing side effects of an anticancer drug, preferably used for acceleration of healing of a wound, and in addition, preferably used for acceleration of normalization of a blood glucose level and for alleviating a pathological state of leukemia.
    Type: Application
    Filed: December 8, 2014
    Publication date: October 22, 2015
    Inventors: Naoyuki MORIYA, Yukiko MORIYA, Koji KUBOTA
  • Patent number: 8802433
    Abstract: Disclosed is a highly effective macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages using an active component derived from natural products. A culture obtained by culturing microorganisms belonging to the genus Aureobasidium (Aureobasidium sp.) is used as the active component of the macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages. By means of the macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages, macrophage phagocytosis can be activated, and cytokine production in macrophages can be promoted. In particular, a macrophage phagocytosis-activating composition can activate the phagocytosis of cancer cells or cells damaged or destroyed by anticancer drugs.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: August 12, 2014
    Assignee: Aureo Co., Ltd.
    Inventors: Naoyuki Moriya, Yukiko Moriya, Yasuhiro Nikawa, Yukitoshi Nagahara, Hidekazu Tamegai, Tadaaki Miyazaki
  • Publication number: 20140199346
    Abstract: Provided is a therapeutic agent for an influenza virus infectious disease, which utilizes an active ingredient derived from a natural product and has an excellent effect. The therapeutic agent for an influenza virus infectious disease includes, as an active ingredient, a ?-glucan-containing composition obtained from a culture of a microorganism belonging to Aureobasidium sp. The therapeutic agent is capable of preventing an influenza virus infectious disease from becoming serious and is capable of promoting the healing of the influenza virus infectious disease.
    Type: Application
    Filed: March 28, 2014
    Publication date: July 17, 2014
    Applicant: AUREO CO., LTD.
    Inventors: Naoyuki MORIYA, Yukiko MORIYA, Yasuhiro NIKAWA, Tamiko NISHINO, Kisato KUSANO, Tadaaki MIYAZAKI
  • Publication number: 20120329154
    Abstract: Disclosed is a highly effective macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages using an active component derived from natural products. A culture obtained by culturing microorganisms belonging to the genus Aureobasidium (Aureobasidium sp.) is used as the active component of the macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages. By means of the macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages, macrophage phagocytosis can be activated, and cytokine production in macrophages can be promoted. In particular, a macrophage phagocytosis-activating composition can activate the phagocytosis of cancer cells or cells damaged or destroyed by anticancer drugs.
    Type: Application
    Filed: December 3, 2010
    Publication date: December 27, 2012
    Applicant: Aureo Co., Ltd.
    Inventors: Naoyuki Moriya, Yukiko Moriya, Yasuhiro Nikawa, Yukitoshi Nagahara, Hidekazu Tamegai, Tadaaki Miyazaki
  • Publication number: 20120202771
    Abstract: Provided is a therapeutic agent for an influenza virus infectious disease, which utilizes an active ingredient derived from a natural product and has an excellent effect. The therapeutic agent for an influenza virus infectious disease includes, as an active ingredient, a ?-glucan-containing composition obtained from a culture of a microorganism belonging to Aureobasidium sp. The therapeutic agent is capable of preventing an influenza virus infectious disease from becoming serious and is capable of promoting the healing of the influenza virus infectious disease.
    Type: Application
    Filed: October 7, 2010
    Publication date: August 9, 2012
    Applicant: AUREO CO., LTD.
    Inventors: Naoyuki Moriya, Yukiko Moriya, Yasuhiro Nikawa, Tamiko Nishino, Kisato Kusano, Tadaaki Miyazaki
  • Patent number: 8183031
    Abstract: It is intended to utilize ?-glucan produced by a bacterium belonging to Aureobasidium sp. From a bacterium belonging to Aureobasidium sp., a mutant with little pigment accumulation is constructed by a mutagenesis means of, for example, irradiating with ultraviolet light or treating with a mutagen. A culture obtained by culturing this mutant in a liquid culture medium is usable as a composition with a large ?-glucan content without showing any intense dark green color caused by the accumulation of melanin-like pigments. This composition may be taken as such as a functional food having the physiologically active functions of the ?-glucan-containing composition. Alternatively, it may be added to foods, drinks. food additives, cosmetics and so on.
    Type: Grant
    Filed: August 3, 2005
    Date of Patent: May 22, 2012
    Assignee: Aureo Co., Ltd.
    Inventors: Naoyuki Moriya, Yukiko Moriya, Koji Kubota
  • Publication number: 20100068184
    Abstract: The present invention provides a living body healing, having an accelerating activity in the regeneration ability relating to the cure of damages of cells or tissues caused by toxicity of a drug or a wound in a living body, having high safety, and also not causing any side effect even administered for a long period of time. Problems are solved by a living body healing accelerator containing as an active constituent a mixture of a culture solution obtained after cultivation of a microorganism belonging to the Aureobasidium sp. and mycelia of the microorganism cultivated in the culture solution. The living body healing accelerator of the present invention is preferable used for reducing side effects of an anticancer drug, preferably used for acceleration of healing of a wound, and in addition, preferably used for acceleration of normalization of a blood glucose level and for alleviating a pathological state of leukemia.
    Type: Application
    Filed: October 22, 2007
    Publication date: March 18, 2010
    Applicant: AUREO CO., LTD.
    Inventors: Naoyuki Moriya, Yukiko Moriya, Koji Kubota
  • Publication number: 20080293669
    Abstract: It is intended to utilize ?-glucan produced by a bacterium belonging to Aureobasidium sp. From a bacterium belonging to Aureobasidium sp., a mutant with little pigment accumulation is constructed by a mutagenesis means of, for example, irradiating with ultraviolet light or treating with a mutagen. A culture obtained by culturing this mutant in a liquid culture medium is usable as a composition with a large ?-glucan content without showing any intense dark green color caused by the accumulation of melanin-like pigments. This composition may be taken as such as a functional food having the physiologically active functions of the ?-glucan-containing composition. Alternatively, it may be added to foods, drinks. food additives, cosmetics and so on.
    Type: Application
    Filed: August 3, 2005
    Publication date: November 27, 2008
    Applicant: AUREO CO., LTD.
    Inventors: Naoyuki Moriya, Yukiko Moriya, Koji Kubota
  • Publication number: 20050272694
    Abstract: The present invention provides a composition containing ?-glucan in which the physiologically active effects of ?-1,3-1,6-glucan contained in a cultured composition of a bacterium belonging to the genus Aureobasidium sp. are further enhanced, and a constipation-relieving drug, preparation an immunopotentiator, and a skin moistening agent using the composition. A composition containing ?-glucan, which contains a cultured composition containing ?-1,3-1,6-glucan obtained by culturing a bacterium belonging to the genus Aureobasidium sp. and lactic acid bacterium cells, is obtained. This composition containing ?-glucan is employed as an active ingredient of a constipation-relieving drug, an immunopotentiator, or a skin moistening agent. Aureobasidium pullulans M-1 (FERM BP-08615) is preferable as the bacterium belonging to the genus Aureobasidium sp. Moreover, Enterococcus faecalis is preferable as the lactic acid bacterium. It is still preferable that the lactic acid bacterium has been killed by heating.
    Type: Application
    Filed: March 4, 2004
    Publication date: December 8, 2005
    Applicant: AUREO CO., LTD
    Inventors: Naoyuki Moriya, Yukiko Moriya, Kenji Suzuki